with malignant potential. 3, 5 NETs from the gastrointestinal tract, liver, and pancreas are graded according to their mitotic count and/or Ki-67 proliferation index as: grade 1 (less than two mitosis and/or Ki-67 < 3%); grade 2 (2-20 mitosis and/or Ki-67 3-20%), and grade 3 (> 20 mitosis and/or Ki-67 > 20%). 5, 6 NETs of the lung are classified into low grade (typical carcinoid tumors), intermediate grade (atypical carcinoid tumors), and high grade (small and large cell neuroendocrine carcinomas) based on the mitotic count (<2, 2-10 and >10), tumor necrosis, and tumor morphology (small cells vs. large cell). 6, 7 The aim of this study is to evaluate the diagnostic accuracy of fine needle aspiration (FNA) in diagnosing metastatic NETs to the liver and determining the grade and origin of these metastases. 
| M A TER I A L A N D M ETH OD S

| RE S U L TS
Of the 271 patients included in the study, 160 were males (59%) and 111 were females (41%) with ages that ranged from 7 to 88 years (Table 1) . High-grade NETs, including small cell and poorly differenti- There is scant cytoplasm. The nuclei are oval, pleomorphic with salt and pepper chromatin without distinct nucleoli. There is prominent nuclear molding with frequent apoptosis and mitosis ( Figure 2 ).
The most common primary sites were lung (44%; 119/271), followed by pancreas (19%; 51/271) and small intestine (8%; 21/271) ( Table 3 ). Among metastatic low-grade NETs, which included low-grade pancreatic and gastrointestinal NETs (G1, G2), carcinoid and atypical carcinoid tumors, the pancreas was the most common primary site (37, 
Low Grade
Neuroendocrine tumors,low grade (G1, G2) 100 36.9% Pheochromocytoma 3 1.1 % 37%) followed by metastasis from unknown primary (23, 23%), and the small intestine (21, 21%) ( Table 4 ). The FNA diagnosis was confirmed by histopathology in all 121 cases that had concurrent surgical biopsies or resections. Concurrent core biopsies were performed on selected cases. In the majority of cases, the diagnoses were rendered based on direct smears with or without cell blocks and supported by ancillary immunocytochemical stains that were either performed on the cell block or on the direct smears through cell transfer technique. Chromogranin, synaptophysin, and Ki67 were routinely performed on cases in
which the tumor cells demonstrate neuroendocrine morphology.
| D I SCUSSION
Tumors with neuroendocrine differentiation are a heterogeneous group of tumors that include carcinoid tumors, islet cell tumors, small cell carcinomas, large cell neuroendocrine carcinomas, pheochromocytomas, paragangliomas, medullary carcinomas of the thyroid, and others.
According to the WHO classification, the term NET is the preferred term to refer to both carcinoid tumors of the gastrointestinal tract and islet cell tumors of the pancreas. 6 However, carcinoid and atypical car- for the neuroendocrine markers, especially for chromogranin. 1 It is apparent that high-grade tumors, evident by high mitosis with or without necrosis, are also more likely to be poorly differentiated in nature.
However, some tumors do show a well-differentiated architecture, while expressing a high mitotic count (>20/HPF) and a high Ki-67 proliferation index (>20%) The term high-grade well-differentiated NETs has been proposed for this situation. 1, 8 For many years, FNA cytology alone or in combination with core biopsy specimens has been used to diagnose both primary and metastatic liver tumors. According to Kuo et al. 9 the sensitivity of FNA for the diagnosis of liver tumors is 78% while the specificity is 97%, with improvements to 85% and 99% when FNA is combined with histological examination of core biopsies. According to that study, the reported in the literature. 11 
| C ONC LUSI ON
FNA is an accurate method for the diagnosis of metastatic NETs to the liver. In fact, for those cases with follow-up histology, there were no discrepancies between the FNA and histologic diagnoses. There were significantly more high-grade (62%) than low-grade (38%) metastatic NETs to the liver. In our practice, lung (44%), pancreas (19%), and small intestine (8%) were the most common primary sites of origin of NETs that metastasized to the liver. As reported by others, a primary site could not be established in a significant minority of patients (16%). 
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